Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Blaha

Showing results (181-190 of 919) with videos related to

Pageof 92
Sort By:
JACC. Cardiovascular Imaging|August 12, 2017
Coronary Artery Calcium Scoring: Is It Time for a Change in Methodology?Michael J Blaha, Martin Bødtker Mortensen, Sina Kianoush, et al.
American Heart Journal|October 23, 2024
Brief report: U.S. trends in use of colchicine by cardiologists and other specialties, 2018 to 2024Michael Khorsandi, Omar Mhaimeed, Omar Dzaye, et al.
Global Heart|October 16, 2016
Providing Evidence for Subclinical CVD in Risk AssessmentMichael J Blaha, Joseph Yeboah, Mahmoud Al Rifai, et al.
European Cardiology|January 15, 2020
Electronic Cigarettes and Cardiovascular Risk: Science, Policy and the Cost of CertaintyOlusola A Orimoloye, Albert D Osei, Sm Iftekhar Uddin, et al.
Clinical Pharmacology and Therapeutics|February 21, 2013
Cardiovascular disease prevention: matching evidence-based algorithms with individualized careR Madanieh, R K Hasan, O F Anusionwu, et al.
American Journal of Preventive Cardiology|July 30, 2021
Ten things to know about ten imaging studies: A preventive cardiology perspective ("ASPC top ten imaging")Harold E Bays, Amit Khera, Michael J Blaha, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 16, 2025
E-cigarette Use and Incident Cardiometabolic Conditions in the All of Us Research ProgramJohn Erhabor, Zhiqi Yao, Erfan Tasdighi, et al.
Current Atherosclerosis Reports|November 24, 2022
Transitioning to GLP-1 RAs and SGLT2 Inhibitors as the First Choice for Managing Cardiometabolic Risk in Type 2 DiabetesKunal K Jha, Rishav Adhikari, Erfan Tasdighi, et al.
The American Journal of Cardiology|October 21, 2011
Effects of physical activity on cardiovascular diseaseHaitham M Ahmed, Michael J Blaha, Khurram Nasir, et al.
Current Opinion in Cardiology|October 24, 2024
Beyond the Agatston calcium score: role of calcium density and other calcified plaque markers for cardiovascular disease predictionAlexander C Razavi, Seamus P Whelton, Roger S Blumenthal, et al.
Pageof 92

Showing results (181-190 of 919) with videos related to

Sort By:
Pageof 92
JACC. Cardiovascular Imaging|August 12, 2017
Coronary Artery Calcium Scoring: Is It Time for a Change in Methodology?Michael J Blaha, Martin Bødtker Mortensen, Sina Kianoush, et al.
American Heart Journal|October 23, 2024
Brief report: U.S. trends in use of colchicine by cardiologists and other specialties, 2018 to 2024Michael Khorsandi, Omar Mhaimeed, Omar Dzaye, et al.
Global Heart|October 16, 2016
Providing Evidence for Subclinical CVD in Risk AssessmentMichael J Blaha, Joseph Yeboah, Mahmoud Al Rifai, et al.
European Cardiology|January 15, 2020
Electronic Cigarettes and Cardiovascular Risk: Science, Policy and the Cost of CertaintyOlusola A Orimoloye, Albert D Osei, Sm Iftekhar Uddin, et al.
Clinical Pharmacology and Therapeutics|February 21, 2013
Cardiovascular disease prevention: matching evidence-based algorithms with individualized careR Madanieh, R K Hasan, O F Anusionwu, et al.
American Journal of Preventive Cardiology|July 30, 2021
Ten things to know about ten imaging studies: A preventive cardiology perspective ("ASPC top ten imaging")Harold E Bays, Amit Khera, Michael J Blaha, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 16, 2025
E-cigarette Use and Incident Cardiometabolic Conditions in the All of Us Research ProgramJohn Erhabor, Zhiqi Yao, Erfan Tasdighi, et al.
Current Atherosclerosis Reports|November 24, 2022
Transitioning to GLP-1 RAs and SGLT2 Inhibitors as the First Choice for Managing Cardiometabolic Risk in Type 2 DiabetesKunal K Jha, Rishav Adhikari, Erfan Tasdighi, et al.
The American Journal of Cardiology|October 21, 2011
Effects of physical activity on cardiovascular diseaseHaitham M Ahmed, Michael J Blaha, Khurram Nasir, et al.
Current Opinion in Cardiology|October 24, 2024
Beyond the Agatston calcium score: role of calcium density and other calcified plaque markers for cardiovascular disease predictionAlexander C Razavi, Seamus P Whelton, Roger S Blumenthal, et al.
Pageof 92